Vimarsana
Biggest News Aggregation in the World

Page 7 - Dtx Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dtx Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dtx Pharma Today - Breaking & Trending Today

Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China - Vimarsana News

Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a Sino Biopharm’s subsidiary, receives IND approval from the NMPA to initiate the clinical development in mainland China of lanifibranor in... | May 25, 2023

Stock Market | FinancialContent Business Page - Vimarsana News

Stock Market | FinancialContent Business Page

FinancialContent fully hosted finance channel

invoX Pharma Completes Acquisition of F-star Therapeutics, Inc. - Vimarsana News

invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.

invoX Pharma Limited ("invoX"), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited ("Sino Biopharm") (HKEX 1177 HK) with an advancing pipeline of innovative products, today announces

F-star Therapeutics, Inc.: F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma - Vimarsana News

F-star Therapeutics, Inc.: F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma

Parties expect the merger to be completed promptly following the successful completion of the ongoing Tender OfferCAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 07, 2023(NASDAQ: FSTX) ("F-star"

RNA therapeutics: the key to treat rare disease? - Vimarsana News

RNA therapeutics: the key to treat rare disease?

This interview highlights Dr Arthur Suckow’s insights into how his team uses RNA therapeutics to treat rare diseases.